CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells

Xiaoxue Jiang,Libo Xing,Yingjie Chen,Rushi Qin,Shuting Song,Yanan Lu,Sijie Xie,Liyan Wang,Hu Pu,Xin Gui,Tianming Li,Jie Xu,Jiao Li,Song Jia,Dongdong Lu
DOI: https://doi.org/10.1016/j.omtn.2020.11.009
2021-03-01
Abstract:<p>CircRNA is a newly identified special class of non-coding RNA (ncRNA) that plays an important regulatory role in the progression of certain diseases. Herein, our results indicate that CircMEG3 is down-regulated expression and negatively correlated with the expression of telomerase-related gene Cbf5 in human liver cancer. Moreover, CircMEG3 inhibits the growth of human liver cancer stem cells <em>in vivo and in vitro</em>. CircMEG3 inhibits the expression of m6A methyltransferase METTL3 dependent on HULC. Moreover, CircMEG3 inhibits the expression of Cbf5, a component of telomere synthetase H/ACA RNP (catalyst RNA pseudouracil modification) through METTL3 dependent on HULC.Thereby, Circ MEG3 inhibits telomerase activity and shortens telomere lifespan dependent on HULC and Cbf5 in human liver cancer stem cell. Strikingly, increased Cbf5 abrogates the ability that Circ MEG3 inhibits malignant differentiation of human liver cancer stem cells. In summary, these observations provides with an important basic informations for finding effective liver cancer therapeutic targets.</p>
What problem does this paper attempt to address?